ISU Petasys Co., Ltd. (007660.KS)
KRW 26550.0
(0.19%)
KRW 26550.0
(0.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 675.33 Billion | 642.92 Billion | 469.62 Billion | 514.18 Billion | 514.23 Billion | 560.33 Billion |
| Cost of Revenue | 560.62 Billion | 479.01 Billion | 384.12 Billion | 467.26 Billion | 487.78 Billion | 503.55 Billion |
| Gross Profit | 114.7 Billion | 163.9 Billion | 85.49 Billion | 46.92 Billion | 26.45 Billion | 56.77 Billion |
| Operating Expenses | 52.53 Billion | 47.28 Billion | 38.62 Billion | 44.96 Billion | 50.41 Billion | 49.27 Billion |
| Selling, General and Administrative Expenses | 26.17 Billion | 19.87 Billion | 17.01 Billion | 21.5 Billion | 24.34 Billion | 25.71 Billion |
| Research and Development Expenses | - | 7.13 Million | 3.43 Billion | 2.62 Billion | 3.17 Billion | 2.51 Billion |
| Other Expenses | 28.1 Billion | 27.39 Billion | 21.6 Billion | 23.46 Billion | 26.07 Billion | 360.87 Million |
| Cost and Expenses | 613.16 Billion | 526.3 Billion | 422.74 Billion | 512.22 Billion | 538.19 Billion | 552.83 Billion |
| Operating Income | 62.16 Billion | 116.61 Billion | 46.87 Billion | -50.36 Million | -19.02 Billion | 7.5 Billion |
| Interest Expense | 11.5 Billion | 8.45 Billion | 7.48 Billion | 10.02 Billion | 10.82 Billion | 9.09 Billion |
| Income Tax Expense | 6.93 Billion | 7.49 Billion | 11.35 Billion | 5.13 Billion | 19.3 Billion | 7.25 Billion |
| Earnings before Tax | 54.65 Billion | 107.82 Billion | 43.01 Billion | -8.37 Billion | -71.79 Billion | -116.49 Million |
| Net Income | 47.72 Billion | 102.47 Billion | 31.65 Billion | -13.5 Billion | -91.09 Billion | -6.76 Billion |
| Earnings Per Share Basic | 755.00 | 1620.22 | 708.11 | -300.47 | -2049.29 | -153.86 |
| Earnings Per Share Diluted | 754.56 | 1620.22 | 708.11 | -300.47 | -2049.29 | -153.86 |
| Weighted Average Shares Outstanding | 63.2 Million | 63.24 Million | 44.7 Million | 44.94 Million | 44.45 Million | 43.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 63.24 Million | 63.24 Million | 44.7 Million | 44.94 Million | 44.45 Million | 43.99 Million |
| Gross Margin | 0.17 | 0.25 | 0.18 | 0.09 | 0.05 | 0.10 |
| EBIT Margin | 0.12 | 0.21 | 0.15 | 0.04 | 0.01 | 0.06 |
| Profit Margin | 0.07 | 0.16 | 0.07 | -0.03 | -0.18 | -0.01 |
| EBITDA | 81.51 Billion | 128.96 Billion | 65.28 Billion | 33.99 Billion | -35.5 Billion | 35.03 Billion |
| Earnings Before Tax Margin | 0.09 | 0.18 | 0.10 | -0.00 | -0.04 | 0.01 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 204.73 Billion | 199.61 Billion | 675.33 Billion | 173.31 Billion | 166.21 Billion | 163.82 Billion |
| Cost of Revenue | 162.83 Billion | 162.05 Billion | 560.62 Billion | 145.93 Billion | 139.39 Billion | 134.89 Billion |
| Gross Profit | 41.9 Billion | 37.55 Billion | 114.7 Billion | 27.37 Billion | 26.82 Billion | 28.93 Billion |
| Operating Expenses | 14.39 Billion | 14.54 Billion | 52.53 Billion | 16.8 Billion | -13.65 Billion | -10.66 Billion |
| Selling, General and Administrative Expenses | 13.35 Billion | 13.65 Billion | - | 16.17 Billion | 13.65 Billion | 10.66 Billion |
| Research and Development Expenses | 2.23 Million | 8.43 Million | - | - | -117 Thousand | 221 Thousand |
| Other Expenses | -1.03 Billion | -881.33 Million | -2.69 Billion | -634.11 Million | -27.31 Billion | -21.32 Billion |
| Cost and Expenses | 177.23 Billion | 176.6 Billion | 613.16 Billion | 162.74 Billion | 139.39 Billion | 134.89 Billion |
| Operating Income | 27.5 Billion | 23 Billion | 62.16 Billion | 10.56 Billion | 13.16 Billion | 18.26 Billion |
| Interest Expense | 3.22 Billion | 3.17 Billion | 11.5 Billion | 3.26 Billion | 2.73 Billion | 2.86 Billion |
| Income Tax Expense | 4.84 Billion | 3.83 Billion | 6.93 Billion | 91.41 Million | 2.08 Billion | 1.17 Billion |
| Earnings before Tax | 26.9 Billion | 21.39 Billion | 54.67 Billion | 8.32 Billion | 10.3 Billion | 16.73 Billion |
| Net Income | 22.04 Billion | 17.54 Billion | 47.72 Billion | 8.21 Billion | 8.21 Billion | 15.56 Billion |
| Earnings Per Share Basic | 348.54 | 277.37 | - | 129.83 | 129.91 | 246.14 |
| Earnings Per Share Diluted | 348.54 | 277.37 | - | 129.83 | 129.91 | 246.14 |
| Weighted Average Shares Outstanding | 63.24 Million | 63.24 Million | 63.24 Million | 63.24 Million | 63.24 Million | 63.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 63.24 Million | 63.24 Million | 63.24 Million | 63.24 Million | 63.24 Million | 63.24 Million |
| Gross Margin | 0.20 | 0.19 | 0.17 | 0.16 | 0.16 | 0.18 |
| EBIT Margin | 0.16 | 0.14 | - | 0.09 | 0.16 | 0.18 |
| Profit Margin | 0.11 | 0.09 | 0.07 | 0.05 | 0.05 | 0.10 |
| EBITDA | 33.32 Billion | 28.52 Billion | - | 15.4 Billion | 26.82 Billion | 28.93 Billion |
| Earnings Before Tax Margin | 0.13 | 0.12 | 0.09 | 0.06 | 0.08 | 0.11 |
1065
HESTERBIO
COR
ACTX
1966
0089